IL17A
Basic information
Region (hg38): 6:52186375-52190638
Previous symbols: [ "CTLA8", "IL17" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL17A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 11 | 0 | 5 |
Variants in IL17A
This is a list of pathogenic ClinVar variants found in the IL17A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-52186457-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
6-52186476-G-A | not specified | Benign (Jan 24, 2024) | ||
6-52187660-C-G | not specified | Uncertain significance (Nov 17, 2023) | ||
6-52187713-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
6-52187718-A-T | not specified | Uncertain significance (May 03, 2023) | ||
6-52187769-A-G | not specified | Uncertain significance (Mar 31, 2024) | ||
6-52187781-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
6-52188798-T-C | Benign (Jun 19, 2021) | |||
6-52189060-A-G | not specified | Uncertain significance (Jun 13, 2022) | ||
6-52189095-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
6-52189097-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
6-52189126-A-T | not specified | Uncertain significance (May 31, 2023) | ||
6-52189179-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
6-52189226-G-A | Benign (Jun 27, 2018) | |||
6-52189240-T-C | not specified | Uncertain significance (Apr 05, 2023) | ||
6-52189451-G-A | Benign (Jun 19, 2021) | |||
6-52190541-C-T | Benign (Feb 18, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL17A | protein_coding | protein_coding | ENST00000340057 | 3 | 4252 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0430 | 0.857 | 125702 | 0 | 18 | 125720 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.275 | 85 | 92.4 | 0.919 | 0.00000544 | 998 |
Missense in Polyphen | 16 | 26.268 | 0.6091 | 285 | ||
Synonymous | -1.51 | 48 | 36.4 | 1.32 | 0.00000194 | 324 |
Loss of Function | 1.35 | 3 | 6.78 | 0.442 | 4.72e-7 | 67 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.0000618 | 0.0000616 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ligand for IL17RA and IL17RC (PubMed:17911633). The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC (PubMed:18684971). Involved in inducing stromal cells to produce proinflammatory and hematopoietic cytokines (PubMed:8676080). {ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971, ECO:0000269|PubMed:8676080}.;
- Pathway
- Inflammatory bowel disease (IBD) - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);IL17 signaling pathway;Allograft Rejection;Development and heterogeneity of the ILC family;Interleukin-4 and 13 signaling;T-Cell antigen Receptor (TCR) Signaling Pathway;JAK STAT MolecularVariation 1;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;JAK STAT pathway and regulation;GPCR signaling-G alpha i;IL23-mediated signaling events;IL27-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.740
Intolerance Scores
- loftool
- 0.309
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.68
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.514
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il17a
- Phenotype
- digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- apoptotic process;inflammatory response;immune response;cell-cell signaling;cell death;regulation of signaling receptor activity;cytokine-mediated signaling pathway;positive regulation of interleukin-23 production;positive regulation of osteoclast differentiation;positive regulation of transcription by RNA polymerase II;fibroblast activation;interleukin-17-mediated signaling pathway
- Cellular component
- extracellular region;extracellular space
- Molecular function
- cytokine activity;protein binding